4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Tsuruha Holdings Inc. (3391) operates in the Pharmaceutical Retailers industry and is headquartered in Sapporo, Japan with about 27,681 employees. Its market capitalization is roughly JPY 1.10 trillion. In the fiscal year ended 2026-02-28, 3391 reported JPY 1.45T in revenue and JPY 42.7B in net income.
Tsuruha Holdings Inc., together with its subsidiaries, operates drugstores in Japan. The company sells pharmaceutical, cosmetic, miscellaneous goods and food products.
Interactive charts & full statements →
| Income statement | 2026-02-28 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|
| Total Revenue | JPY 1.45T | JPY 1.03T | JPY 970.1B | JPY 915.7B |
| Gross Profit | JPY 444.0B | JPY 312.3B | JPY 293.4B | JPY 271.5B |
| Operating Income (EBIT) | JPY 63.0B | JPY 47.2B | JPY 45.6B | JPY 40.6B |
| Net Income | JPY 42.7B | JPY 21.7B | JPY 25.3B | JPY 21.4B |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-02-28 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|
| Dividends Paid | (JPY 11.9B) | (JPY 13.5B) | (JPY 9.7B) | (JPY 8.1B) |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-02-28 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|
| Total Assets | JPY 1.65T | JPY 549.6B | JPY 539.8B | JPY 562.4B |
| Total Liabilities | JPY 752.3B | JPY 244.3B | JPY 235.7B | JPY 278.3B |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 3391 viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms